Mallinckrodt Responds Following Settlement: Reaffirms 'Commitment to Ensuring Safe and Appropriate Use of its Specialty Generic Opioid Products,' Highlights 'Settlement Contains No Admission of Liability for Civil Penalties for Relevant Conduct'